Extraction of Histones from Clinical Specimens for Epigenetic Profiling by Mass Spectrometry

Area of Science:

• Epigenetics
• Cancer Biology
• Proteomics

Background:

• Epigenetic mechanisms, including histone variants and post-translational modifications (PTMs), play a crucial role in cancer development and progression.
• Altered histone PTM patterns are common in cancers and can serve as diagnostic and prognostic biomarkers.
• There is a need for robust methods to profile histone PTMs in clinical samples for comprehensive tumor characterization.

Purpose of the Study:

• To develop and present a protocol for efficient histone extraction from diverse clinical cancer samples.
• To enable unbiased and comprehensive profiling of histone PTMs for cancer epigenetics research.
• To facilitate the identification of novel epigenetic biomarkers for cancer diagnosis and prognosis.

Main Methods:

• Developed a protocol for efficient histone protein extraction from snap frozen, OCT frozen, and FFPE clinical biopsies.
• Utilized high-performance liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) for bottom-up proteomic analysis.
• Focused on the detection and quantification of key histone modifications, specifically lysine acetylations and methylations.

Main Results:

• Successfully extracted high-quality and sufficient quantities of histone proteins from various clinical sample types.
• Demonstrated the capability of the LC-MS/MS workflow for robust detection and quantification of histone PTMs.
• Enabled detailed analysis of histone modifications in primary tumor samples, offering insights into epigenetic landscapes.

Conclusions:

• The presented protocol provides a valuable tool for comprehensive histone PTM profiling in clinical cancer samples.
• This methodology enhances the characterization of tumor epigenetics, potentially leading to new diagnostic and prognostic biomarkers.
• The workflow supports the integration of epigenetic data into multi-layered cancer molecular profiling.